Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-08

Clinical Trial Update: Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer [NA]

View source ↗

Summary

Clinical trial investigating enalapril maleate with doxorubicin hydrochloride in women with breast cancer has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
  • Enalapril maleate (enalapril maleate)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2019-05-08